SPL 9.20% 9.5¢ starpharma holdings limited

Dendrimer-Trastuzumab Starpharma Holdings Limited Drug Names(s):...

  1. 12,800 Posts.
    lightbulb Created with Sketch. 1392
    Dendrimer-Trastuzumab

    Starpharma Holdings Limited

    Drug Names(s): Dendrimer-Trastuzumab, DEP-Trastuzumab
    Description: Dendrimer-Trastuzumab is a proprietary formulation wherein trastuzumab is formulated with the dendrimer delivery platform.

    Dendrimers (1-100nm) are constructed by the successive addition of layers of branching groups. Each new layer is called a generation. The final generation incorporates the surface molecules that give the dendrimer the desired function for pharmaceutical, life science, chemical, electronic and materials applications.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.008(9.20%)
Mkt cap ! $39.14M
Open High Low Value Volume
9.0¢ 9.5¢ 8.8¢ $334.2K 3.710M

Buyers (Bids)

No. Vol. Price($)
2 50354 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 22908 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.